Ardsley Advisory Partners LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Ardsley Advisory Partners LP
✚
CRD #301116
SEC #801-114966
CIK #0000900529
AUM 1,635.7 M (2026-05-06)
Employees 11 (64% Investors, 0% Brokers)
Fees
Minimum
Phone203-564-4200
Address105 Rowayton Ave
Norwalk, CT 06853
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
17001360102068034002010201520212027
CIK Period
0000900529
Sector Form 13F Holdings Value ($M)
Sandisk Corp 56.7
Advanced Micro Devices Inc 54.0
Sezzle Inc 36.9
Ikonics Corp 23.7
BrightSpring Health Services Inc 22.7
eBay Inc 22.3
Sunrun Inc 21.4
JDS Uniphase Corp /CA/ 18.6
ARM Holdings PLC /UK 16.6
Shoals Technologies Group Inc 16.5
Amazon Com Inc 16.4
United Therapeutics Corp 16.3
Teva Pharmaceutical Industries Ltd 15.8
Alphabet Inc 15.3
Palo Alto Networks Inc 14.6
Twilio Inc 14.2
Zoom Video Communications Inc 13.6
Primoris Services Corp 13.4
Apple Inc 13.0
Modine Manufacturing Co 12.0
Nanometrics Inc 11.9
Synnex Corp 11.6
Brookdale Senior Living Inc 11.1
Enphase Energy Inc 10.8
Allegiant Travel Co 10.6
Okta Inc 10.4
Equinix Inc 10.4
HUT 8 Corp 10.4
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold AUM
HF Ardsley World Information Technology Offshore Fund Ltd [2026-02-24] 76.1 M 7.6 M
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Ridgecrest Partners Fund LP [2019-01-23] 30.3 M 25.8 M
Filed 2024-11-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Conway Fund LP [2018-03-22] 14.0 M 5.3 M
Filed 2019-11-21 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Duckdive Fund LP [2017-03-16] 17.1 M 25.6 M
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Partners Advanced Healthcare Fund LP [2015-03-17] 285.6 M 332.4 M
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Healthcare Fund LP [2013-03-25] 23.4 M 10.3 M
Filed 2020-11-20 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley Partners Fund II LP [2012-02-14] 54.3 M
HF Ardsley Sustainable Opportunities Fund LP [2012-02-14] 98.2 M 309.6 M
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Ardsley World Information Technology Fund LP [2012-02-14] 76.1 M 108.5 M
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 9 1,426.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 2 209.5
Total 11 1,635.7
By Discretionary
Discretionary 11 1,635.7
Non-Discretionary 0 0.0
Total 11 1,635.7
By Non-United States Persons
Non-United States Persons 738.1
United States Persons 897.6
Total 11 1,635.7
Form D Directors Role # Filings # Firms 2011 - 2026
Philip Hempleman Executive Officer 8 3
Ardsley Partners I GP LLC Executive Officer 8 3
Spencer Hempleman Executive Officer 8 3
Ardsley Advisory Partners LP Promoter 8 3
Ardsley Partners I Executive Officer 3 3
Ardsley Advisory Partners Promoter 3 2
Ardsley Advisory Promoter 2 2
Ardsley Partners I Ardsley Partners I Executive Officer 2 2
EDGAR Form CIK 2011 - 2026
13F-HR [0000900529]
3 [0000900529]
4 [0000900529]
SC 13D [0000900529]
SC 13G [0000900529]
Form 13D/13G Filer Form 13D/13G Subject Filed
Ardsley Advisory Partners LP Aspire Biopharma Holdings Inc [2026-02-12]
Ardsley Advisory Partners LP Bioceres Crop Solutions Corp [2023-01-25]
Ardsley Advisory Partners LP Stronghold Digital Mining Inc [2022-02-08]
Ardsley Advisory Partners LP Marrone Bio Innovations Inc [2022-02-08]
Ardsley Advisory Partners LP Cantaloupe Inc [2022-02-08]
Ardsley Advisory Partners LP USA Technologies Inc [2020-02-07]
Ardsley Advisory Partners LP Just Energy Group Inc [2020-02-07]
Ardsley Advisory Partners LP Sunopta Inc [2019-02-12]
Ardsley Advisory Partners Marrone Bio Innovations Inc [2018-02-07]
Ardsley Advisory Partners American Superconductor Corp /DE/ [2017-05-08]
View All
Firm Profile (Form ADV)
Discretionary AUM$0.7B
Clients1 (45 non-US)
ServesInstitutional
Fund TypesHedge Fund
LEI549300GQR5ULS7W2C050
Form 3/4/5 Subject 2011 - 2026
Ardsley Partners Renewable Energy Fund LP
Ardsley Advisory Partners GP LLC
Ardsley Partners Advanced Healthcare Fund LP
Ardsley Partners I GP LLC
Marrone Bio Innovations Inc
Ardsley Advisory Partners LP
Hempleman Philip J
Ardsley Partners Fund II LP
Ardsley Ridgecrest Partners Fund LP
Ardsley Duckdive Fund LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Marrone Bio Innovations Inc MBII
Warrant · derivative
2021-11-11 Option exercise 618,014 $0.75 463,510
Marrone Bio Innovations Inc MBII
Common Stock
2021-11-11 Option exercise 618,014 $0.75 463,510
Marrone Bio Innovations Inc MBII
Common Stock
2021-03-12 Option exercise 741,617 $0.75 556,213
Marrone Bio Innovations Inc MBII
Warrant · derivative
2021-03-12 Option exercise 741,617 $0.75 556,213
Marrone Bio Innovations Inc MBII
Common Stock
2020-12-31 Other 50,000 $1.26 63,000
Marrone Bio Innovations Inc MBII
Common Stock
2020-12-31 Other 50,000 $1.26 63,000
Marrone Bio Innovations Inc MBII
Common Stock
2020-12-14 Option exercise 1,648,037 $0.75 1,236,028
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-12-14 Option exercise 1,648,037 $0.75 1,236,028
Marrone Bio Innovations Inc MBII
Common Stock
2020-09-15 Option exercise 343,341
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-09-15 Option exercise 343,341 $0.75 257,506
SunOpta Inc STKL
Common Stock
2020-08-18 Sell 2,300,000 $6.00 13,800,000
SunOpta Inc STKL
Common Stock
2020-08-18 Sell 1,000,000 $6.00 6,000,000
SunOpta Inc STKL
Common Stock
2020-08-06 Sell 12,500 $6.77 84,625
SunOpta Inc STKL
Common Stock
2020-08-05 Sell 50,000 $6.31 315,500
SunOpta Inc STKL
Common Stock
2020-08-05 Sell 25,000 $6.56 164,000
SunOpta Inc STKL
Common Stock
2020-08-05 Sell 25,000 $7.10 177,500
Marrone Bio Innovations Inc MBII
Common Stock
2020-05-01 Option exercise 429,176
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-05-01 Option exercise 429,176
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-04-29 Grant 741,617
Marrone Bio Innovations Inc MBII
Warrant · derivative
2020-04-29 Grant 1,648,037
showing 20 of 83 most recent transactions
Comparable Firms State AUM
Deltroit Asset Management UK LLP
✚
1,655.8 M
Richbrook Advisors LP
✚
NY 1,652.9 M
Bain Capital Partnership Strategies LP
✚
MA 1,652.2 M
Park Presidio Capital LLC
✚
CA 1,647.5 M
Tree Line Advisors Hong Kong Ltd
✚
1,638.0 M
Zweig-Dimenna Associates LLC
✚
NY 1,633.5 M
Shellback Capital LP
✚
MA 1,629.0 M
Columbus Hill Capital Management LP
✚
NJ 1,614.4 M
Hayfin Capital Management LLC
✚
NY 1,614.0 M
Teewinot Capital Advisers LLC
✚
CT 1,611.9 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com